Generex is making a pretty big bet in diagnostic testing with a $10 Million financing proposal for the acquisition of infectious disease and cancer diagnostics company awaiting EUA approval from FDA for COVID-19 rapid diagnostic assay system.

Fyi- Trump’s announcement involves blood plasma research done at the Mayo Clinic.